Together, these data indicate that the enriched HMGA2 in TRCs promotes their stemness and cancer progression but is potentially detrimental to the survival and recovery of irradiated TRCs, while exosomal miR-194-5p from dying tumor cells transiently reverses the effects of HMGA2 under radiotherapy to preserve the TRCs. This evidence concerns the gene HMGA2 and neoplasm.